Form 4: Incyte Executive Receives Stock Grant
Insider Transaction (Form 4)
Patrick A Mayes, EVP & Chief Scientific Officer of Incyte Corp, reported multiple transactions in common stock on July 16, 2026.
Summary
- Grant/award: acquired 5,916 Common Stock on July 16, 2026; holds 63,628 after (Direct).
- Grant/award: acquired 14,790 Performance Shares on July 16, 2026; holds 14,790 after (Direct).
- Grant/award: acquired 25,538 Employee Stock Option (right to buy) on July 16, 2026; holds 25,538 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Patrick A Mayes — Officer (EVP & Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Common Stock | 5,916 | — | — | 63,628 |
| 2026-07-16 | Grant/award | Performance Shares | 14,790 | — | — | 14,790 |
| 2026-07-16 | Grant/award | Employee Stock Option (right to buy) | 25,538 | — | — | 25,538 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (5,916 shares) |
| 2026-07-16 | Grant/award (14,790 shares) |
| 2026-07-16 | Grant/award (25,538 shares) |
Keywords
insider transaction, Form 4, INCY, INCYTE CORP, neutral, Patrick A Mayes
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.